FDA Warns Texas Compounder for Adulterated Drugs

Drug Industry Daily
A A
Serious deficiencies in sterile drug production at Greenpark Compounding in Houston, Texas, may put patients at risk, the FDA said in a warning letter to the compounder.

To View This Article:

Login

Subscribe To Drug Industry Daily